Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual property (English, HTML)

View metadata and access the original English HTML file: Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual property.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-29

As a consequence of the review, authorization and oversight of COVID-19 drugs under the Regulations, manufacturers may benefit from intellectual property protections that are available in respect of a submission that results in an NOC.

Access original file